Programing Cells in a Predictable and Scalable Way

The Bio Report - En podcast af Levine Media Group - Onsdage

Kategorier:

Mark Kotter, founder and CEO of Bit.Bio, discusses the company’s platform technology, its effort to develop cell therapies, and its growing offering of precision reprogramed human cells for drug development.

Visit the podcast's native language site